Saturday, December 03, 2016 10:06:32 AM
Carp, I included that in my long email to Ben. I told him that I was "assuming" that we were in a quiet period. He forwarded my email to Kim and Jon, and they each had a "positive" response to what I said.
There is a chance that we will receive a PR either on Monday or Tuesday, probably the latter. Not sure what it will entail (if it comes), but it "could" address some of the issues I raised, and that would allay some of the angst on the board.
I am more BULLISH about KBLB than ever before. This is the calm before the storm. Lots of things will be happening next year. Also, I expect at least two PR's before the end of the year. I am excited (if they come) to see what they might entail. My guesses are either a second international location or another domestic location or perhaps the announcement of a contract. With KBLB, anything is possible, since there are so many things happening.
This is the time to be happy, since big things are upon us. I can see the light at the end of the tunnel a lot more clearly now. As time passes, it will become brighter and stronger.
Hang in there. Bob
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM